MX9205577A - Derivados de carbamato de 4-amino-3-isoxazolidinonas, 3-amino-1-hidroxipirrolidin-2-onas y analogos del acido 1-amino-1-ciclopropanocarboxilico, un procedimiento para su preparacion y su uso como medicamentos. - Google Patents

Derivados de carbamato de 4-amino-3-isoxazolidinonas, 3-amino-1-hidroxipirrolidin-2-onas y analogos del acido 1-amino-1-ciclopropanocarboxilico, un procedimiento para su preparacion y su uso como medicamentos.

Info

Publication number
MX9205577A
MX9205577A MX9205577A MX9205577A MX9205577A MX 9205577 A MX9205577 A MX 9205577A MX 9205577 A MX9205577 A MX 9205577A MX 9205577 A MX9205577 A MX 9205577A MX 9205577 A MX9205577 A MX 9205577A
Authority
MX
Mexico
Prior art keywords
amino
preparation
isoxazolidinones
analogs
hydroxyprolrolidin
Prior art date
Application number
MX9205577A
Other languages
English (en)
Inventor
Denise Mary Flanagan
Lawrence Leo Martin
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of MX9205577A publication Critical patent/MX9205577A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Fats And Perfumes (AREA)
MX9205577A 1991-10-01 1992-09-30 Derivados de carbamato de 4-amino-3-isoxazolidinonas, 3-amino-1-hidroxipirrolidin-2-onas y analogos del acido 1-amino-1-ciclopropanocarboxilico, un procedimiento para su preparacion y su uso como medicamentos. MX9205577A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/769,268 US5153193A (en) 1991-10-01 1991-10-01 Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs

Publications (1)

Publication Number Publication Date
MX9205577A true MX9205577A (es) 1993-04-01

Family

ID=25084962

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205577A MX9205577A (es) 1991-10-01 1992-09-30 Derivados de carbamato de 4-amino-3-isoxazolidinonas, 3-amino-1-hidroxipirrolidin-2-onas y analogos del acido 1-amino-1-ciclopropanocarboxilico, un procedimiento para su preparacion y su uso como medicamentos.

Country Status (21)

Country Link
US (1) US5153193A (es)
EP (2) EP1069125A3 (es)
JP (1) JP2703157B2 (es)
KR (2) KR100276143B1 (es)
AT (1) ATE201024T1 (es)
AU (1) AU649882B2 (es)
CA (1) CA2079548C (es)
CZ (1) CZ281982B6 (es)
DE (1) DE69231817T2 (es)
DK (1) DK0535645T3 (es)
ES (1) ES2157201T3 (es)
FI (2) FI102178B (es)
GR (1) GR3036334T3 (es)
HU (1) HU215120B (es)
IL (1) IL103304A (es)
MX (1) MX9205577A (es)
NO (1) NO301884B1 (es)
NZ (1) NZ244540A (es)
PT (1) PT535645E (es)
RU (1) RU2103271C1 (es)
TW (1) TW208009B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231093A (en) * 1991-10-01 1993-07-27 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
IT1253007B (it) * 1991-12-31 1995-07-10 Aesculapius Farma Srl Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5480651A (en) * 1992-03-16 1996-01-02 Regents Of The University Of California Composition and method for treating nicotine craving in smoking cessation
US6323196B1 (en) 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6323195B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US6316439B1 (en) * 1993-10-15 2001-11-13 Aventis Pharamaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
AT403803B (de) * 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
US6372760B1 (en) * 1999-03-31 2002-04-16 Eisai Co., Ltd. Stabilized composition comprising antidementia medicament
EP1181294B1 (de) * 2000-03-31 2004-03-31 Sanochemia Pharmazeutika Aktiengesellschaft Neue derivate und analoga von galanthamin
EP1341541A4 (en) * 2000-11-16 2004-11-17 Alcon Mfg Ltd COMBINATION THERAPY FOR LOWERING AND CONTROLLING THE EYE PRESSURE
AU2004285893B2 (en) * 2003-10-21 2011-12-15 Colucid Pharmaceuticals, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
US7549431B1 (en) * 2004-11-10 2009-06-23 Gore Enterprise Holdings, Inc. Protective enclosure
TWI487486B (zh) 2009-12-01 2015-06-11 Syngenta Participations Ag 以異唑啉衍生物為主之殺蟲化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1974782U (de) 1967-07-04 1967-12-14 Filzfabrik Fulda G M B H & Co Matratzenschoner.
US4791107A (en) 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
KR100195399B1 (ko) * 1987-05-04 1999-06-15 보니데이비스 알쯔하이머 병 치료용 의약
GB8727792D0 (en) * 1987-11-27 1987-12-31 Merck Sharp & Dohme Therapeutic agents
GB8823605D0 (en) * 1988-10-07 1988-11-16 Merck Sharp & Dohme Therapeutic agents
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
US5061721A (en) * 1989-03-15 1991-10-29 G. D. Searle & Co. Composition containing d-cycloserine and d-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use

Also Published As

Publication number Publication date
DE69231817T2 (de) 2001-09-27
KR100271416B1 (en) 2000-11-15
CA2079548C (en) 2002-03-19
FI102178B1 (fi) 1998-10-30
GR3036334T3 (en) 2001-11-30
NO923803D0 (no) 1992-09-30
JPH05194519A (ja) 1993-08-03
EP1069125A3 (en) 2001-10-10
NO301884B1 (no) 1997-12-22
TW208009B (es) 1993-06-21
CZ281982B6 (cs) 1997-04-16
AU649882B2 (en) 1994-06-02
ATE201024T1 (de) 2001-05-15
KR100276143B1 (ko) 2001-03-02
NO923803L (no) 1993-04-02
CZ299092A3 (en) 1993-10-13
FI981710A (fi) 1998-08-06
HU9203129D0 (en) 1992-12-28
HU215120B (hu) 1998-09-28
FI102178B (fi) 1998-10-30
US5153193A (en) 1992-10-06
EP0535645A2 (en) 1993-04-07
HUT65277A (en) 1994-05-02
PT535645E (pt) 2001-09-27
CA2079548A1 (en) 1993-04-02
KR930007947A (ko) 1993-05-20
ES2157201T3 (es) 2001-08-16
IL103304A0 (en) 1993-02-21
FI981710A0 (fi) 1998-08-06
FI924370A (fi) 1993-04-02
EP1069125A2 (en) 2001-01-17
NZ244540A (en) 1995-04-27
FI924370A0 (fi) 1992-09-29
AU2606592A (en) 1993-04-08
RU2103271C1 (ru) 1998-01-27
IL103304A (en) 1996-12-05
DE69231817D1 (de) 2001-06-13
JP2703157B2 (ja) 1998-01-26
EP0535645B1 (en) 2001-05-09
EP0535645A3 (en) 1993-08-04
DK0535645T3 (da) 2001-08-13

Similar Documents

Publication Publication Date Title
MX9205577A (es) Derivados de carbamato de 4-amino-3-isoxazolidinonas, 3-amino-1-hidroxipirrolidin-2-onas y analogos del acido 1-amino-1-ciclopropanocarboxilico, un procedimiento para su preparacion y su uso como medicamentos.
ATE71375T1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeure ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
ES2085865T3 (es) Analogos de dermorfina, sus metodos de preparacion, composiciones farmaceuticas, y metodos de tratamiento terapeutico que los emplean.
ES2082755T3 (es) Derivados de acido 3-desmetil-mevalonico, procedimiento para su preparacion, preparados farmaceuticos a base de estos compuestos, su utilizacion asi como productos intermedios.
FR2416889A1 (fr) Derives esters de l'acide dihydro-1,4-pyridine-dicarboxylique-3,5, medicaments a base de ces derives et leur procede de production
MX21088A (es) N-heteroanil-purin-6-aminas, y un proceso para su preparacion y su uso como medicamentos.
ES2147749T3 (es) Procedimiento para la preparacion de derivados de ciano-metoxiiminometilo.
FR2358406A1 (fr) Derives d'acides 5-aroyl-1,2-dihydro-3h-pyrrolo (1,2-a)pyrrole-1-carboxyliques, leur obtention et leur application a titre de medicament
ATE62908T1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
ES2016305B3 (es) Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso.
NO167978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler.
ES2033256T3 (es) Procedimiento para preparar derivados fluorados de la vitamina d3.
NO903291D0 (no) Renin-hemmende aminooligohydroksy-derivater.
ES2039386T3 (es) Procedimiento para preparar oxolabdanos y su utilizacion para preparar medicamentos.
ES8708213A1 (es) Un procedimiento para preparar un derivado de 1-benzhidril--4-cinamilpiperazina
ES2124277T3 (es) Heteroarenilpiperazinas, un procedimiento para su preparacion y su uso como medicamentos.
TH6975EX (th) การใช้ไอซอกซาโซลิโนนเป็นยาที่ว่องไวต่อสมอง
TH6975A (th) การใช้ไอซอกซาโซลิโนนเป็นยาที่ว่องไวต่อสมอง
TH5602EX (th) สารประกอบทางเภสัชวิทยาชนิดใหม่
JPS52133969A (en) Synthesis of optically active lactam
MX9405283A (es) Empleo de las fenalquilaminas para la fabricacion de medicamentos paradisminuir el colesterol y los medicamentos que las incluyen.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees